Searched for
CIPLA USA
Cipla sets sights on first-wave gains from rollout of Keytruda BiosimilarCipla has partnered with Qilu Pharmaceutical to commercialize a biosimilar of Keytruda, which is a major cancer treatment. The patent for t...- When nothing is cheap, winners may come from any corner: 19 stocks with downside to upside potential of -28% to plus 22%Because each pharma company took a different road, they no longer rise and fall together. Where any one of them stands in 10 years depends ...
- Cipla, China's Qilu partner for US launch of Merck's Keytruda biosimilarCipla said its US unit has entered an exclusive partnership with China’s Qilu Pharmaceutical to license QL2107, a biosimilar of Merck’s can...
- Stocks in news: Kwality Walls, AU Small Finance Bank, YES Bank, PB Fintech, Tata PowerIndian markets faced pressure on Friday, losing some recent gains due to cautious global sentiment and profit-taking. Several companies lik...
- Cipla USA recalls Nilotinib anti-cancer capsules over manufacturing issue: USFDACipla USA is recalling over 400 cartons of its generic anti-cancer drug Nilotinib Capsules (150 mg and 200 mg) due to a manufacturing issue...
- Cipla recalls over 400 cartons of cancer drug in US: FDACipla USA is recalling over 400 cartons of its anti-cancer drug Nilotinib Capsules. The recall is due to a manufacturing issue where the ca...
- Sun Pharma, Cipla recall products in US over manufacturing issues: USFDASun Pharma and Cipla, two leading drug manufacturers from India, are taking precautionary measures by recalling products in the United Stat...
- Cipla shares slide 5% after temporary halt in key drug manufacturingCipla shares fell sharply on Friday after a halt in Lanreotide Injection production due to USFDA observations at its Greek partner. Supply ...
- Cipla shares in focus after receiving CDSCO nod to launch inhalation insulinCipla has secured exclusive rights to distribute and market Afrezza, an inhalable insulin, in India. Developed by MannKind, Afrezza offers ...
- Cipla gets CDSCO nod to launch inhalation insulinCipla received approval from CDSCO to distribute and market Afrezza, an inhalable insulin, in India. Developed by MannKind, Afrezza offers ...
- Cipla unit recalls one lot of medication in US due to seal integrity issueDrug major Cipla's subsidiary is voluntarily recalling one lot of medication in the US due to seal integrity issues. InvaGen Pharmaceutical...
- Glenmark, Strides Pharma, Cipla recall products in the USThe USFDA noted in its report that the company, a subsidiary of Mumbai-based drug firm, is recalling the affected lot due to "blister packa...
- Cipla recalls 7,228 bottles of overactive bladder treatment drug in AmericaAs per the USFDA, a class II recall is initiated in a situation in which use of, or exposure to, a violative product may cause temporary or...
- Scaled up remdesivir production two-fold: Cipla"We have scaled up the production of remdesivir by 2x from the last wave of the pandemic. Given the unprecedented demand for the drug, we h...
- Cipla settles case with Amgen Inc involving generic cinacalcet hydrochloride tabletsA formal stipulation of dismissal has been filed with the court and is awaiting signature by the presiding Judge, the filing added.
- Cipla recalls 4,800 bottles of anti-HIV tablets from USAs per the latest Enforcement Report by the United States Food and Drug Administration (USFDA), the reason for the recall of the bottles is...
- Cipla arm secures marketing rights for cancer drug in USCipla USA, Inc, a subsidiary of the company will be marketing the drug in strengths of 150 and 500 mg tablets.
- DRL, Cipla, Aurobindo among others to buy products from TevaThe remedy requires Teva to divest the drug portfolio to 11 firms and marks the largest drug divestiture order in an FTC pharmaceutical mer...
- Cipla hopeful of achieving 12-15 per cent revenue growth in FY13Pharma major Cipla Ltd today said it is hopeful of achieving 12-15 per cent revenue growth in the current financial year.
- RK Bammi is Sami group chairmanDr RK Bammi, a member of the board of directors of Sami Labs, Bangalore, has been appointed as the chairman of the Sami Group of Companies.
Load More
